Tenaya Therapeutics, Inc. Common Stock (TNYA)
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Tenaya Therapeutics, Inc. Common Stock (TNYA) is listed on Nasdaq, where it has traded since July 30, 2021.
- Listed On
- Nasdaq
- Listed Since
- July 30, 2021
- Employees
- 70
- Market Cap
- $137M
About Tenaya Therapeutics, Inc. Common Stock
Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 98 institutions reported holding TNYA, with 53.8 million shares worth $39.7 million in aggregate. The largest reported holder was Vanguard, with 8.2 million shares worth $6.0 million. Of the 5 largest holders listed below, 4 added shares and 1 reduced its position during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Vanguard | 8,173,709 | $6M | Reduced 14.87% |
| Millennium Management | 6,429,648 | $5M | Added 17.83% |
| Citadel Advisors | 4,566,774 | $3M | Added 8.73% |
| Renaissance Technologies | 4,281,100 | $3M | Added 15.28% |
| BlackRock | 4,008,719 | $3M | Added 8.23% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is TNYA?
Tenaya Therapeutics, Inc. Common Stock (TNYA) is listed on Nasdaq, where it has traded since July 30, 2021.
Who are the largest institutional holders of TNYA?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of TNYA were Vanguard, Millennium Management and Citadel Advisors.
How many institutions own TNYA?
98 institutions reported a position in TNYA for the quarter ended June 30, 2026, worth $39.7 million in total.
Did institutions buy or sell TNYA last quarter?
Of the 5 largest reported holders, 4 added shares and 1 reduced its position during the quarter. Every reported holder and its change is on the SentiSense ownership page for TNYA.
Every reported institutional holder, plus insider and congressional trades in TNYA, on SentiSense.